Antiobiotice Iasi 1Q Net Profit Flat At RON3.2M, Sales Revenue Up 19% To RON65M

05.16.2019 By Ecaterina Craciun

Pharmaceutical company Antibiotice Iasi (ATB.RO) on Thursday said its sales revenue grew 10% year-on-year to RON65 million in January-March 2019, and its net profit stagnated at RON3.27 million.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:: Antiobiotice Iasi; , results

Comment

Username:
Password: